Table 2. Blood test results for children attending Ebola holding units and Ebola treatment units for whom blood test results were available, Western Area, Sierra Leone, August 2014–March 2015*.
| Laboratory value (reference) | Median value among patients who died | Median value among patients who survived | p value† |
|---|---|---|---|
| Leukocyte count (4–11), × 109/L | 33, n = 7 | 9.2, n = 22 | 0.067 |
| Lymphocyte count (1–3.2), × 109/L | 6.1, n = 7 | 2.9, n = 21 | 0.007 |
| Granulocyte count (2.5–7.5), × 109/L | 19.9, n = 7 | 4.9, n = 22 | 0.009 |
| Hemoglobin (135–175), g/L | 123, n = 7 | 110, n = 22 | 0.097 |
| Platelets (150–430), × 10/L | 376, n = 7 | 179, m = 22 | 0.17 |
| Sodium (128–145), mmol/L | 127, n = 10 | 131, n = 24 | 0.11 |
| Potassium (3.6–5.1), mmol/L | 3.9, n = 7 | 4.1, n = 23 | 0.9 |
| Urea (2.5–7.9), mmol/L | 16.2, n = 11 | 4.2, n = 24 | <0.001 |
| Creatinine (53–106), mmol/L | 120, n = 10 | 49, n = 24 | 0.003 |
| Albumin (33–50), g/L | 26, n = 11 | 31, n = 20 | 0.25 |
| Aspartate transaminase (11–35), U/L | 2,000, n = 8 | 159, n = 17 | 0.001 |
| Alanine transaminase (10–48), U/L | 667, n = 11 | 131, n = 18 | <0.001 |
| Creatine kinase (39–380), U/L | 2,544, n = 8 | 623, n = 18 | 0.13 |
| C-reactive Protein (0–7.5), mg/L | 96, n = 10 | 8, n = 17 | 0.007 |
| Viral cycle threshold, range‡ | 14.3–35.8, n = 40 | 17–38.2, n = 42 | NA |
*n values indicate number of patients in category for whom value was available. NA, not applicable †Wilcoxon rank-sum test used because of small sample size. ‡Different reference ranges used.